Osamu Matsuno

956 total citations
49 papers, 681 citations indexed

About

Osamu Matsuno is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Osamu Matsuno has authored 49 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 22 papers in Physiology and 17 papers in Epidemiology. Recurrent topics in Osamu Matsuno's work include Asthma and respiratory diseases (19 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers) and Respiratory and Cough-Related Research (9 papers). Osamu Matsuno is often cited by papers focused on Asthma and respiratory diseases (19 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers) and Respiratory and Cough-Related Research (9 papers). Osamu Matsuno collaborates with scholars based in Japan, United States and United Kingdom. Osamu Matsuno's co-authors include Eishi Miyazaki, Toshihide Kumamoto, Masaru Ando, Takuya Ueno, Shin‐ichi Nureki, Seijiro Minamoto, Hajime Kataoka, Ryuichi Takenaka, Emiko Ono and Yasunori Higuchi and has published in prestigious journals such as Circulation, CHEST Journal and European Respiratory Journal.

In The Last Decade

Osamu Matsuno

48 papers receiving 667 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Osamu Matsuno Japan 14 351 204 127 113 102 49 681
Yutaka Hirasawa Japan 13 539 1.5× 196 1.0× 136 1.1× 106 0.9× 25 0.2× 27 874
Brian D. Modena United States 13 206 0.6× 389 1.9× 73 0.6× 31 0.3× 94 0.9× 26 770
Kenji Tsushima Japan 15 517 1.5× 168 0.8× 205 1.6× 50 0.4× 33 0.3× 52 853
Norihiro Kaneko Japan 12 256 0.7× 188 0.9× 210 1.7× 169 1.5× 24 0.2× 57 698
Snježana Kos Netherlands 12 327 0.9× 331 1.6× 104 0.8× 28 0.2× 18 0.2× 25 789
Zhiwei Xu China 15 145 0.4× 122 0.6× 37 0.3× 71 0.6× 45 0.4× 29 528
Benoît Dupont France 12 113 0.3× 42 0.2× 99 0.8× 114 1.0× 24 0.2× 57 418
Keith Sacco United States 12 66 0.2× 45 0.2× 74 0.6× 63 0.6× 91 0.9× 51 670
Meng Xia United States 18 877 2.5× 273 1.3× 143 1.1× 100 0.9× 10 0.1× 44 1.2k
S Barocci Italy 16 71 0.2× 67 0.3× 69 0.5× 54 0.5× 20 0.2× 53 693

Countries citing papers authored by Osamu Matsuno

Since Specialization
Citations

This map shows the geographic impact of Osamu Matsuno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Osamu Matsuno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Osamu Matsuno more than expected).

Fields of papers citing papers by Osamu Matsuno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Osamu Matsuno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Osamu Matsuno. The network helps show where Osamu Matsuno may publish in the future.

Co-authorship network of co-authors of Osamu Matsuno

This figure shows the co-authorship network connecting the top 25 collaborators of Osamu Matsuno. A scholar is included among the top collaborators of Osamu Matsuno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Osamu Matsuno. Osamu Matsuno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matsuno, Osamu, et al.. (2025). Paradoxical effects of dupilumab in allergic bronchopulmonary aspergillosis. Annals of Allergy Asthma & Immunology. 135(5). 588–589. 1 indexed citations
2.
Matsuno, Osamu. (2023). Factors Affecting the Ability to Discontinue Oral Corticosteroid Use in Patients with EGPA Treated with Anti-Interleukin-5 Therapy. International Archives of Allergy and Immunology. 185(2). 116–123. 3 indexed citations
3.
Matsuno, Osamu & Seijiro Minamoto. (2022). Benralizumab monotherapy was insufficient to induce remission in patients with active eosinophilic granulomatosis with polyangiitis. Respiratory Medicine Case Reports. 40. 101763–101763. 1 indexed citations
4.
Matsuno, Osamu & Seijiro Minamoto. (2021). COVID-19 in a Patient With Severe Eosinophilic Asthma on Benralizumab Therapy: A Case Report and Review of Literature. Cureus. 13(12). e20644–e20644. 1 indexed citations
5.
Matsuno, Osamu & Seijiro Minamoto. (2020). Rapid effect of benralizumab for severe asthma with chronic rhinosinusitis with nasal polyps. Pulmonary Pharmacology & Therapeutics. 64. 101965–101965. 18 indexed citations
6.
Matsuno, Osamu & Seijiro Minamoto. (2019). Eosinophils depletion therapy for severe asthma management following favorable response to mepolizumab. Respiratory Medicine Case Reports. 28. 100899–100899. 9 indexed citations
7.
Shimizu, Kazunori, Osamu Matsuno, Hiroshi Morishita, et al.. (2017). Spontaneous Regression of Allergic Bronchopulmonary Mycosis Due to <i>Curvularia lunata</i>. Internal Medicine. 57(2). 243–246. 2 indexed citations
9.
Matsuno, Osamu. (2012). Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches. Respiratory Research. 13(1). 39–39. 210 indexed citations
10.
Matsuno, Osamu, et al.. (2010). The use of frequency scale for the symptoms of GERD in assessment of gastro-oesophageal reflex symptoms in asthma. Allergologia et Immunopathologia. 38(1). 20–24. 6 indexed citations
11.
Matsuno, Osamu, Emiko Ono, Takuya Ueno, et al.. (2009). Increased serum ADAM8 concentration in patients with drug-induced eosinophilic pneumonia-ADAM8 expression depends on a the allergen route of entry. Respiratory Medicine. 104(1). 34–39. 15 indexed citations
12.
Kataoka, Hajime & Osamu Matsuno. (2008). Age-Related Pulmonary Crackles (Rales) in Asymptomatic Cardiovascular Patients. The Annals of Family Medicine. 6(3). 239–245. 19 indexed citations
13.
Ando, Masaru, Eishi Miyazaki, Toshiyuki Okubo, et al.. (2008). Amoxapine‐associated acute respiratory distress. Respirology. 13(1). 149–151. 1 indexed citations
14.
Matsuno, Osamu, Ryuichi Takenaka, Emiko Ono, et al.. (2008). Reduced IgG levels found during acute eosinophilic pneumonia, which normalize during recovery from disease. Respiratory Medicine. 102(6). 899–903. 2 indexed citations
15.
Ono, Emiko, Masami Taniguchi, Haruhisa Mita, et al.. (2008). Increased urinary leukotriene E4concentration in patients with eosinophilic pneumonia. European Respiratory Journal. 32(2). 437–442. 11 indexed citations
16.
Matsuno, Osamu, Toshihide Kumamoto, & Yasunori Higuchi. (2008). ADAM8 in Allergy. Inflammation & Allergy - Drug Targets. 7(2). 108–112. 15 indexed citations
17.
Matsuno, Osamu, Toshiyuki Okubo, Emiko Ono, et al.. (2007). Drug-Induced Lymphocyte Stimulation Test is not Useful for the Diagnosis of Drug-Induced Pneumonia. The Tohoku Journal of Experimental Medicine. 212(1). 49–53. 30 indexed citations
18.
Miyazaki, Eishi, Shin‐ichi Nureki, Emiko Ono, et al.. (2007). Circulating Thymus- and Activation-Regulated Chemokine/CCL17 Is a Useful Biomarker for Discriminating Acute Eosinophilic Pneumonia From Other Causes of Acute Lung Injury. CHEST Journal. 131(6). 1726–1734. 24 indexed citations
19.
Matsuno, Osamu, Takuya Ueno, Ryuichi Takenaka, et al.. (2007). Acute eosinophilic pneumonia caused by Candida albicans. Respiratory Medicine. 101(7). 1609–1612. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026